FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a solid dosage form for oral administration, containing 5-chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)]-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide in an amorphous form or in thermodynamically metastable crystalline modification with a fast-release active substance. The active substance (I) is transformed in the amorphous state by a solution method with using acetic acid as a solvent and adding suitable excipients, preferentially, polyvinylpyrrolidone, or by an extrusion melting method with using polymer - hydroxypropyl cellulose or polyvinylpyrrolidone. The active substance (I) is transformed in the thermodynamically metastable crystalline modification by a melting method with using suitable excipients, preferentially polyethylene glycol.
EFFECT: dosage forms according to the invention are characterised by high release rate and better solubility of the active substance.
8 cl, 6 ex
Title |
Year |
Author |
Number |
HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE |
2005 |
- Benke Klaus
- Khenk Jan-Olav
|
RU2420290C2 |
TABLETS PREPARATION TECHNOLOGY FOR CGRP-ACTIVE COMPOUNDS |
2015 |
- Johnson, Mary Ann
- Allain, Leonardo Resende
- Eickhoff, W. Mark
- Ikeda, Craig, B.
- Brown, Chad, D.
- Flanagan, Francis, J., Jr.
- Nofsinger, Rebecca
- Marota, Melanie
- Lupton, Lisa
- Patel, Paresh, B.
- Xi, Hanmi
- Xu, Wei
|
RU2696578C1 |
METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION |
2009 |
|
RU2493850C2 |
METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION |
2004 |
|
RU2379036C2 |
METHOD FOR OBTAINING 5-CHLORO-N-(5S)-2-OXO-3-[4-(3-OXO-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHENECARBOXAMIDE IN MODIFICATION II (VERSIONS) |
2006 |
- Grunenberg Alfons
- Lents Jana
- Braun Gerkhard Arnold
- Kajl Birgit
- Tomas Kristian
|
RU2578602C2 |
NOVEL POLYMORPHOUS FORM AND AMORPHOUS FORM OF 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHENE CARBOXAMIDE |
2006 |
- Grunenberg Al'Fons
- Lents Jana
- Braun Gerkhard Arnol'D
- Kajl' Birgit
- Tomas Kristian R.
|
RU2429236C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN |
2009 |
- Gao Dan'Chehn'
- U Dzhen-Sehn'
- Lu Vehj-Shu
- Chehn' Shouchiun
- Ko Pehj-Chun'
- Chehn' Chikh-Min
|
RU2542461C2 |
EXTRUDATE WITH SODIUM MYCOPHENOLATE TO PRODUCE PERORAL SOLID DOSAGE FORM |
2018 |
- Khazanova Elena Sergeevna
- Nogaj Sergej Yurevich
- Filippova Evgeniya Aleksandrovna
|
RU2723255C2 |
THERMODYNAMICALLY RESISTANT FORM OF (R)-3-[[(4-FLUOROPHENYL)- SULFONYL]AMINO]-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE-9-PROPANOIC ACID (RAMATROBAN) |
1998 |
- Grunenberg Al'Fons
- Vol' Karl-Khajnts
- Foges Klaus-Piter
|
RU2220137C2 |
HYDROCODON PREPARATIVE SUSTAINED-RELEASE FORMULATIONS |
2000 |
- Oshlak Bendzhamin
- Khuang Khua-Pin
- Tonelli Al'Fred P.
- Masselink Dzhon
|
RU2230556C2 |